75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Search
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Parasiticides
Parasiticides
Partnering Culture
Partnering Culture
Depression
Depression
Vaccines
Vaccines
Corporate Profile
Corporate Profile
What Our Partners Say
What Our Partners Say
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Our Responsibility
Human Health Our Responsibility
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Human Health Partnering Connect with Us
Human Health Partnering Connect with Us
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.
Clinical Studies
Clinical Studies
Boehringer Ingelheim Austria - Value through Innovation
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience.
Poultry
Poultry
Artrial Fibrillation
Artrial Fibrillation
Metabolic Diseases
Metabolic Diseases
Diabetes
Diabetes
Horses
Horses
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
More Potential: For Communities & Our People
More Potential: For Communities & Our People
Stroke
Stroke
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.